Connected Drug Delivery Devices Market Growth Is Reshaping Competitive Advantage Across The Industry
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Connected Drug Delivery Devices Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The market for connected drug delivery devices has experienced remarkable expansion in recent years, with projections indicating a surge from $9.27 billion in 2025 to $11.48 billion in 2026, reflecting a compound annual growth rate of 23.8%. This historic period’s growth has been driven by factors such as the rising uptake of devices for managing chronic conditions, a heightened prevalence of diabetes and respiratory ailments, progress in smart syringe and inhaler technologies, growing efforts to digitize healthcare systems, and increased public understanding of the importance of sticking to medication regimens.
The connected drug delivery devices market is anticipated to experience rapid expansion in the coming years, reaching $27.02 billion by 2030 with a compound annual growth rate (CAGR) of 23.9%. This projected growth during the forecast period is driven by increasing demand for remote patient monitoring, the expansion of interconnected healthcare systems, the incorporation of AI-driven predictive analytics, the rising prevalence of wearable drug delivery devices, and favorable government policies promoting digital health adoption. Key trends shaping this period include personalized monitoring of medication adherence, solutions for remote patient oversight, integration with electronic health records (EHR), data-guided dose adjustments, and the provision of real-time alerts and notifications.
Download A Free Sample Report For Comprehensive Market Insights:
Connected Drug Delivery Devices Market Growth Factors Supporting Long-Term Expansion
The growing significance of remote patient monitoring is anticipated to drive expansion in the connected drug delivery device market moving forward. Remote patient monitoring refers to a healthcare approach that leverages technology to observe patient health and medical information from a distance. Connected drug delivery devices support RPM by enabling precise monitoring of medication usage and adherence, allowing for prompt interventions, and delivering customized care management. For example, in May 2024, the Journal of Medical Internet Research, a peer-reviewed publication based in Canada, reported that 38.78% of adults in the United States had utilized telehealth services within the previous year. Consequently, the rising emphasis on remote patient monitoring is fueling growth in the connected drug delivery device market.
Connected Drug Delivery Devices Market Segmentation Trends And Revenue Drivers
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
Connected Drug Delivery Devices Market Industry Trends Shaping Future Revenue Growth
Key players in the connected drug delivery devices market are prioritizing the development of advanced, durable, and deeply integrated digital health platforms designed to boost treatment convenience, refine monitoring precision, and facilitate effortless connectivity with automated therapy systems. For example, in November 2025, Dexcom, a U.S.-based healthcare firm, announced the launch of its G7 15 Day continuous glucose monitor in the United States starting December 1, 2025, targeting adults with diabetes. This device, which recently secured FDA approval, stands as the longest-wearing CGM available, providing up to 15.5 days of usage with an enhanced accuracy MARD of 8%. Upon its release, it will be accessible through DME providers and covered for Medicare beneficiaries. The upgraded sensor works seamlessly with the iLet Bionic Pancreas, Omnipod 5, and soon Tandem pumps, while also powering Dexcom’s new Smart Basal insulin optimization system. Offering fewer sensor replacements, water-resistant construction, smartwatch compatibility, and streamlined data logging, the G7 15 Day is designed to offer enhanced ease of use and superior long-term blood sugar management.
Connected Drug Delivery Devices Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, Findair Sp. z.o.o, Omron Healthcare Co. Ltd, Omnicell Inc., BD Medical
Access The Complete Connected Drug Delivery Devices Market Report:
Connected Drug Delivery Devices Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the connected drug delivery market in 2025. The regions covered in the connected drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
